Results 91 to 100 of about 4,361 (187)
We investigated the influence of bronchodilating β2-agonists on the activity of human acetylcholinesterase (AChE) and usual, atypical and fluoride-resistant butyrylcholinesterase (BChE). We determined the inhibition potency of racemate and enantiomers of
Anita Bosak +4 more
doaj +1 more source
This graphical abstract illustrates the effects of uncoated and coated mannitol supplementation on ruminal and fecal microbiomes, serum immune indices, antioxidant status, and metabolism in Sunit sheep. Neither uncoated nor coated mannitol altered growth performance.
Min Li +6 more
wiley +1 more source
On novel functions of cholinesterases [PDF]
The non-specificity of cholinesterases to cholinergic innervated tissues, their early onset during embryogenesis of many organisms, and their non-cholinolytic aryl acylamidase activity, indicate that these enzymes are involved with physiological ...
Allebrandt, Karla Viviani
core
Tracking origin and divergence of Cholinesterases and Neuroligins
Cholinesterase activity can be found in all kingdoms of living organism, yet cholinesterases involved in cholinergictransmission appeared only recently in the animal phylum [1].
Chatonnet, Arnaud +5 more
core +2 more sources
Vocal Fold Atrophy in Patients With Alzheimer's Disease and Related Dementias
This is the first study to quantify vocal fold atrophy in patients with Alzheimer's disease and related dementias (AD/ADRD) using endoscopic imaging. Compared with age‐matched controls, AD/ADRD patients showed significantly greater vocal fold bowing and reduced mucosal wave amplitude, while normalized glottal gap area did not differ.
Byron Kim +5 more
wiley +1 more source
Quinuclidine derivatives are potent bioactive compounds investigated as cholinesterase inhibitors with potential intravenous therapeutic application.
Marcelić Lucija +4 more
doaj +1 more source
Neurodegenerative diseases share convergent risk architectures and pathological mechanisms, yet diverge in selective vulnerability, clinical presentation, and therapeutic responsiveness. This review integrates cross‐disease epidemiology, pathophysiology, diagnosis, and treatment, highlighting the transition from symptomatic care toward biomarker‐guided
Zimeng He +4 more
wiley +1 more source
Alzheimer's Disease: Mechanisms and Therapeutic Advances
Alzheimer's disease involves Aβ/tau aggregation, neuroinflammation, BBB leakage, gut–brain dysfunction, and mitochondrial damage, causing neuronal loss. Nanodelivery enables combined small‐molecule and targeted therapies. Disease‐modifying biologics/chemicals, including anti‐Aβ antibodies, raise safety and access concerns. Exercise, cognitive training,
Gaoshuang Fu +4 more
wiley +1 more source
Abstract Background Progressive supranuclear palsy (PSP) is a neurodegenerative disorder characterized by motor, oculomotor and cognitive impairments. Yet disentangling cognitive deficits from motor and oculomotor dysfunction remains a diagnostic and methodological challenge.
Indira Garcia‐Cordero +12 more
wiley +1 more source
Biosensors for testing of cholinesterases' inhibitors [PDF]
Charles University, Faculty of Pharmacy in Hradec Králové Department of Pharmaceutical Chemistry and Pharmaceutical Analysis Student: Bc. Ondřej Keresteš Supervisor: PharmDr. Marta Kučerová, Ph.D. Consultant: pplk. prof. RNDr.
Keresteš, Ondřej
core

